Boehringer Ingelheim’s survodutide shows breakthrough
News builds on previously announced primary endpoint, which showed up to 83.0% of adults achieved statistically significant improvement in metabolic ...
Read moreNews builds on previously announced primary endpoint, which showed up to 83.0% of adults achieved statistically significant improvement in metabolic ...
Read moreAzemiglitazone (MSDC-0602K) working through a newly identified mitochondrial target adds cardiometabolic benefit to GLP-1 receptor agonists Benefit includes preservation of ...
Read moreInvestigational chemotherapy-free regimen of amivantamab plus lazertinib addresses a significant unmet need as most patients with EGFR-mutated NSCLC have high-risk ...
Read moreLas Vegas has long been synonymous with entertainment, offering headlining residencies from global superstars, tour stops from today’s top acts ...
Read moreWhen: May 17–22, 2024Where: San Diego Convention Center (SDCC) | 111 Harbor Dr. ...
Read moreDALLAS, May 15, 2024 (GLOBE NEWSWIRE) -- New research from The Cooper Institute® and partners at University of Texas (UT) ...
Read moreNew data from Phase 2b SunRISe-1 study show rapid achievement of complete response (CR) with 98 percent achieving a CR ...
Read moreMore than 250 exhibitors already signed up – Leading trade fair for sustainable energy production to take place alongside EuroTier ...
Read moreGlobal ASICS study of 26,000 people reaffirms the connection between movement and the mind and uncovers a direct link between ...
Read moreSANTA CLARA, Calif., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Ushur, the leader in AI-powered Customer Experience Automation™ (CXA), today published ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.